New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease.
about
Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the LungFunctionalized positive nanoparticles reduce mucin swelling and dispersionMucin secretion induced by titanium dioxide nanoparticlesNovel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells.Managing exacerbations of chronic obstructive pulmonary disease.Physical activity and modulation of systemic low-level inflammation.COPD exacerbations . 2: aetiologyDeterminants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.Pathogenesis of bacterial exacerbations of COPD.Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.Optimizing antibiotic selection in treating COPD exacerbationsA new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD.Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells.Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease.CeO nanoparticles attenuate airway mucus secretion induced by TiO nanoparticles
P2860
Q26742160-13960E3A-0CFB-498B-B4C0-20C52EDF0060Q28384444-9FEC8524-21ED-4EF6-82C1-8A2B2F87B865Q28385852-16071000-840E-4E7C-A2E7-2C618EDE66E9Q34684239-57691571-2317-4CCD-9CE1-3EDE0AFC6C94Q35636112-20B2FEB1-F528-48EA-88FF-D509705C5116Q36052536-47293831-FA0D-40AA-B7EF-985617AFAB27Q36173911-4C17E8FC-B743-4208-BC00-B3A44069C608Q36201980-AE4EA570-9E53-4CC1-AC33-CEB6E08687F6Q36414253-424FDA42-0142-4992-949B-80F6B8EA8435Q36526951-40CA5951-7302-4337-9C67-0B0F447D90E3Q36686865-26C1109F-8DCF-4B7E-A1F3-0D31865E425BQ37144420-E138A249-1759-4628-A1A4-83EAE14FC7A2Q37167347-D0574EED-4F0D-4C8A-8DEB-771AA410F97BQ37834142-E0A2B6DA-B30F-4698-A19C-0ACAC736CF3DQ42254984-9833E244-15F0-429C-AB2F-78A31CD21222Q42727329-3E8D4220-D335-492A-BA81-000D653802FFQ43027521-77FB1306-2152-451B-BF59-16E0BDB09031Q47833638-784C48A9-5E20-4561-B762-BE8E156A1B79Q57173634-3FFBCD6B-F6BA-4F76-BDA6-EDF030F797C6
P2860
New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New developments in the pathog ...... obstructive pulmonary disease.
@ast
New developments in the pathog ...... obstructive pulmonary disease.
@en
type
label
New developments in the pathog ...... obstructive pulmonary disease.
@ast
New developments in the pathog ...... obstructive pulmonary disease.
@en
prefLabel
New developments in the pathog ...... obstructive pulmonary disease.
@ast
New developments in the pathog ...... obstructive pulmonary disease.
@en
P1476
New developments in the pathog ...... obstructive pulmonary disease.
@en
P2093
Sanjay Sethi
P304
P356
10.1097/00001432-200404000-00008
P577
2004-04-01T00:00:00Z